Speech-Language Pathologists in Ortonville, MN Accepting Medicare

3 Speech-Language Pathologists found. Showing 1 - 3

Kristen Pearson Ash Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 820 Roy St, Ortonville, MN 56278 Phone: 320-839-4271

Kimberly Starz Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 820 Roy St, Ortonville, MN 56278 Phone: 320-839-4271

Melissa Marihart Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 820 Roy St, Ortonville, MN 56278 Phone: 320-839-4271

News Archive

Study provides insight into physician recommendations to improve HPV vaccination

The risk of developing cervical cancer can be significantly decreased through human papillomavirus vaccination. Despite calls from leading health and professional organizations for universal vaccination for girls ages 11 and 12, the most recently published national data indicate that only 14.5 percent of 11- and 12-year-old girls have received at least one dose of the HPV vaccine and 3 percent have completed the three-dose series. A new Moffitt Cancer Center study provides insight into physician recommendations, one important factor that may contribute to these low levels of uptake.

Gemcitabine may help breast cancer patients with advanced disease live longer

Breast cancer patients with advanced disease live longer when treated with a new drug, gemcitabine, in combination with paclitaxel, a traditional drug, according to results of a landmark global phase III study presented today at the American Society of Clinical Oncology (ASCO) annual meeting.

Cerenis, Novasep awarded French Government funding for development of CER-001 HDL mimetic

Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and other metabolic diseases, and Groupe Novasep (Novasep), a leading supplier of manufacturing solutions to the life sciences industries, announce today that they have received French Government funding through OSEO to finance the development of CER-001, a Cerenis HDL mimetic.

Women with gestational diabetes during first, second pregnancies at increased risk of recurrence

There is an increased risk of recurring gestational diabetes in pregnant women who developed gestational diabetes during their first and second pregnancies, according to a Kaiser Permanente study appearing online in The American Journal of Obstetrics and Gynecology.

Read more Medical News

› Verified 6 days ago